Veristat, Inc.   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Southborough MA United States (1994)

Organization Overview

First Clinical Trial
2011
NCT01433731
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Veristat | Veristat, Inc.